Palatin Technologies
PTN
#10515
Rank
C$28.89 M
Marketcap
C$16.24
Share price
9.37%
Change (1 day)
13,087.74%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -C$6.94 Million

According to Palatin Technologies's latest financial reports the company's current earnings are C$8.84 Million. In 2024 the company made an earning of -C$38.24 Million, an increase over its 2023 earnings that were of -C$46.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$6.94 Million-81.86%
2024 -C$38.24 Million-16.9%
2023 -C$46.02 Million5.99%
2022 -C$43.42 Million-13.7%
2021 -C$50.31 Million33.25%
2020 -C$37.76 Million-172.11%
2019 C$52.35 M2352.33%
2018 C$2.13 M-94.13%
2017 C$36.37 M-154.92%
2016 -C$66.24 Million3.67%
2015 -C$63.89 Million878%
2014 -C$6.54 Million-72.64%
2013 -C$23.88 Million-33.11%
2012 -C$35.7 Million77.71%
2011 -C$20.09 Million
2003 -C$34.02 Million29.93%
2002 -C$26.18 Million36.18%
2001 -C$19.23 Million
1999 -C$15.96 Million6.04%
1998 -C$15.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.87 B-541,884.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$20.81 B-305,913.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$1.13 B-16,758.74%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-C$17.04 Million 150.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$0.23 B-3,513.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-C$0.17 Billion 2,353.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
C$0.13 B-2,097.69%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-C$41.86 Million 514.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-C$82.25 Million 1,108.36%๐Ÿ‡บ๐Ÿ‡ธ USA